Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

PHASE3CompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2006

Conditions
HIV Infections
Interventions
PROCEDURE

Structured Treatment Interruption

DRUG

Zidovudine (ZDV)

DRUG

Lamivudine (3TC)

DRUG

Efavirenz (EFV)

DRUG

Ritonavir (NRV)

DRUG

Indinavir (IDV)

Trial Locations (5)

Unknown

Centre de Prise en Charge et de Formation ACONDA, Abidjan

Centre de Suivi des donneurs de sang, Centre National de Transfusion Sanguine, Abidjan

Centre Intégré de Recherches Biocliniques d'Abidjan, Abidjan

Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan

Unité de Soins Ambulatoires et de Conseil, CHU de Treichville, Abidjan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV